News Avicanna Inc.

Equities

AVCN

CA05368K1003

Market Closed - Toronto S.E. Other stock markets 03:59:34 2024-05-16 pm EDT			5-day change	1st Jan Change
0.35 ^CAD	-4.11%		+11.11%	0.00%

May. 14	Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History	MT
May. 14	Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History	May. 14	MT
Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History	May. 14	MT
Avicanna Brief: Record Q1 revenue of $6.45 million representing a year-over-year increase of 451% compared to Q1 2023	May. 14	MT
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter	May. 14	AQ
Avicanna Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Avicanna Announced Results of Study in Patients with Epidermolysis Bullosa	May. 13	MT
Avicanna Brief: Announcing Results of Study in Patients with Epidermolysis Bullosa	May. 13	MT
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa	May. 13	AQ
Avicanna Raises About $2.1 Million in Non-brokered Private Placement	Apr. 19	MT
Avicanna Announces Closing of Non-brokered Private Placement	Apr. 18	AQ
Avicanna Inc. announced that it has received CAD 2.125584 million in funding	Apr. 17	CI
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study	Apr. 10	AQ
Avicanna Inc. Announces Completion of Topical Gel Observational Real-World Evidence Study	Apr. 10	CI
Transcript : Avicanna Inc., 2023 Earnings Call, Apr 02, 2024	Apr. 02
Avicanna's Q4 Loss Narrows, Revenue Grows	Apr. 02	MT
Avicanna Brief: Reporting $16.8 Million in 2023 Revenue, representing an increase of 314% from 2022	Apr. 02	MT
Avicanna Reports Full Year 2023 Audited Financial Results	Apr. 02	AQ
Avicanna Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Avicanna Announced Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	Mar. 27	MT
Avicanna Brief: Announcing Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	Mar. 27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Avicanna Inc.

Equities

AVCN

CA05368K1003

Summary

Filters